Cargando…
Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
OBJECTIVE: This meta-analysis was performed to evaluate the optimal discontinuation of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation in acute coronary syndrome (ACS) patients. METHODS: A systematic search was conducted without language restrictions using PubMed, the Co...
Autores principales: | Geng, Xue, Zhang, Ya-Nan, Cui, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153186/ https://www.ncbi.nlm.nih.gov/pubmed/32270731 http://dx.doi.org/10.1177/0300060520915052 |
Ejemplares similares
-
Shorter- versus Longer-duration Dual Antiplatelet Therapy in Patients with Diabetes Mellitus Undergoing Drug-eluting Stents Implantation: A Meta-analysis of Randomized Controlled Trials
por: Huang, He, et al.
Publicado: (2016) -
Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
por: Xiang, Chun-Lin, et al.
Publicado: (2017) -
Non-inferiority of 1 month versus longer dual antiplatelet therapy in patients undergoing PCI with drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
por: Bajraktari, Gani, et al.
Publicado: (2022) -
Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015) -
Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
por: Li, Ming-Xuan, et al.
Publicado: (2023)